Expressional profile of cardiac uncoupling protein-2 following myocardial ischemia reperfusion in losartan- and ramiprilat-treated rats

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 15, Issue 3, 2014, Pages 209-217

  Safari, Fatemeh ^a,b   Bayat, Gholamreza ^b,c   Shekarforoush, Shahnaz ^d   Hekmatimoghaddam, Seyedhossein ^a   Anvari, Zahra ^a   Moghadam, Mahdi Forouzandeh ^b   Hajizadeh, Sohrab ^b,e  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

^e INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

Author keywords

Cardiac expression; ischemia reperfusion; losartan; ramiprilat; UCP2

Indexed keywords

LOSARTAN; MESSENGER RNA; RAMIPRILAT; UNCOUPLING PROTEIN 2; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GENE OVEREXPRESSION; HEART HEMODYNAMICS; HEART MITOCHONDRION; HEART PROTECTION; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; HEMODYNAMICS; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; GENE EXPRESSION PROFILING; HEART RATE; HEMODYNAMICS; ION CHANNELS; LOSARTAN; MALE; MITOCHONDRIAL PROTEINS; MYOCARDIAL REPERFUSION INJURY; RAMIPRIL; RATS, WISTAR; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84909964717     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312474050     Document Type: Article

References (43)

1. Nedergaard J, Cannon B. The 'novel' 'uncoupling' proteins UCP2 and UCP3: What do they really do? Pros and cons for suggested functions. Exp Physiol. 2003 ; 88: 65-84
2. Laskowski KR, Russell RR. Uncoupling proteins in heart failure. Curr Heart Fail Rep. 2008 ; 5: 75-79
3. Trenker M, Malli R, Fertschai I, et al. Uncoupling proteins 2 and 3 are fundamental for mitochondrial Ca2+ uniport. Nat Cell Biol. 2007 ; 9: 445-452
4. Murray AJ, Anderson RE, Watson GC, et al. Uncoupling proteins in human heart. Lancet. 2004 ; 364: 1786-1788
5. McMurray JJ. ACE inhibitors in cardiovascular disease - unbeatable?. N Engl J Med. 2008 2008 ; 58: 1615-1616
6. Oyamada S, Bianchi C, Takai S, et al. Impact of acute myocardial ischemia reperfusion on the tissue and blood-borne renin-angiotensin system. Basic Res Cardiol. 2010 ; 105: 513-522
7. González GE, Seropian IM, Krieger ML. Effect of early versus late AT (1) receptor blockade with losartan on postmyocardial infarction ventricular remodeling in rabbits. Am J Physiol Heart Circ Physiol. 2009 ; 297: H375 - H386
8. Safari F, Hajizadeh S, Shekarforoush S, et al. Influence of ramiprilat and losartan on ischemia reperfusion injury in rat hearts. J Renin Angiotensin Aldosterone Syst. 2012 ; 13: 29-35
9. Butz CE, McClelland GB, Brooks GA. MCT1 confirmed in rat striated muscle mitochondria. J Appl Physiol. 2004 ; 97: 1059-1066
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 ; 72: 248-254
11. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001 ; 29: e45
12. McFalls EO, Sluiter W, Schoonderwoerd K, et al. Mitochondrial adaptations within chronically ischemic swine myocardium. J Mol Cell Cardiol. 2006 ; 41: 980-988
13. Nakase T, Yoshida Y, Nagata K. Amplified expression of uncoupling proteins in human brain ischemic lesions. Neuropathol. 2007 ; 27: 442-447
14. Guo P, Mizushige K, Noma T, et al. Association of uncoupling protein-2 expression with increased reactive oxygen species in residual myocardium of the enlarged left ventricle after myocardial infarction. Heart Vessels. 2005 ; 20: 61-65
15. Teshima Y, Akao M, Jones S, et al. Uncoupling protein 2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res. 2003 ; 93: 192-200
16. McLeod C, Aziz A, Hoyt R, et al. Uncoupling proteins 2 and 3 function in concert to augment tolerance to cardiac ischemia. J Biol Chem. 2005 ; 280: 33470-33476
17. Noma T, Nishiyama A, Mizushige K, et al. Possible role of uncoupling protein in regulation of myocardial energy metabolism in aortic regurgitation model rats. FASEB J. 2001 ; 15: 1206-1208
18. Murakami K, Mizushige K, Noma T, et al. Perindopril effect on uncoupling protein and energy metabolism in failing rat hearts. Hypertension. 2002 ; 40: 251-255
19. Brown JE, Thomas S, Digby JE, et al. Glucose induces and leptin decreases expression of uncoupling protein-2 mRNA in human islets. FEBS Lett. 2002 ; 513: 189-192
20. Almsherqi ZA, McLachlan CS, Slocinska MB, et al. Reduced cardiac output is associated with decreased mitochondrial efficiency in the non-ischemic ventricular wall of the acute myocardial-infarcted dog. Cell Res. 2006 ; 16: 297-305
21. Wu Z, Puigserver P, Andersson U, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999 ; 98: 115-124
22. Andrews ZB, Liu ZW, Walllingford N, et al. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature. 2008 ; 454: 846-851
23. Sivitz W, Fink B, Donohoue P. Fasting and leptin modulate adipose and muscle uncoupling protein: Divergent effects between messenger ribonucleic acid and protein expression. Endocrinology. 1999 ; 140: 1511-1519
24. Rodriguez VM, Portillo MP, Pico C, et al. Olive oil feeding up-regulates uncoupling protein genes in rat brown adipose tissue and skeletal muscle. Am J Clin Nutr. 2002 ; 75: 213-220
25. Ealey KN, El-Sohemy A, Archer MC. Effects of dietary conjugated linoleic acid on the expression of uncoupling proteins in mice and rats. Lipids. 2002 ; 37: 853-861
26. Pecqueur C, Alves-Guerra MC, Gelly C, et al. Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem. 2001 ; 23: 8705-8712
27. Hoshovs'ka IuV, Lisovya, Shymans'ka TV, et al. UCP2 and UCP3 gene expression, heart function and oxygen cost of myocardial work changes during aging and ischemia-reperfusion [in Ukrainian]. Fiziol Zh. 2009 ; 55: 26-36
28. Fert-Bober J, Basran RS, Sawicka J, et al. Effect of duration of ischemia on myocardial proteome in ischemia/reperfusion injury. Proteomics. 2008 ; 8: 2543-2555
29. Yang BC, Phillips MI, Zhang YC, et al. Critical role of AT receptor expression after ischemia/reperfusion in isolated rat hearts. Circ Res. 1998 ; 83: 552-559
30. Omura T, Yoshiyama M, Fuminobu I, et al. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats. J Mol Cell Cardiol. 2001 ; 33: 307-316
31. Araki K, Masaki T, Katsuragi I, et al. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension. 2006 ; 48: 51-57
32. Chen YH, Yuan L, Chen YY, et al. The effects of renin-angiotensin system blockade on the liver steatosis in rats on long-term high-fat diet [in Chinese]. Zhonghua Nei Ke Za Zhi. 2008 ; 47: 197-201
33. Piotrkowski B, Fraga CG, de Cavanagh EM. Mitochondrial function and nitric oxide metabolism are modified by enalapril treatment in rat kidney. Am J Physiol Regul Integr Comp Physiol. 2007 ; 292: R1494 - R1501
34. de Cavanagh EM, Piotrkowski B, Basso N, et al. Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J. 2003 ; 17: 1096-1098
35. de Cavanagh EM, Toblli JE, Ferder L, et al. Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine. Am J Physiol Regul Integr Comp Physiol. 2006 ; 290: R1616 - R1625
36. de Cavanagh EM, Ferder L, Toblli JE, et al. Renal mitochondrial impairment is attenuated by AT1 blockade in experimental type I diabetes. Am J Physiol Heart Circ Physiol. 2008 ; 294: H456 - H465
37. Polizio AH, Balestrasse KB, Gornalusse GG, et al. Losartan exerts renoprotection through NAD(P)H oxidase downregulation in a renovascular model of hypertension. Regul Pept. 2009 ; 7: 28-33
38. Otto A, Fontaine J, Berkenboom G. Ramipril treatment protects against nitrate-induced oxidative stress in eNOS-/- mice: An implication of the NADPH oxidase pathway. J Cardiovasc Pharmacol. 2006 ; 48: 842-849
39. Safari F, Hajizadeh S, Moshtaghion SH, et al. Effect of losartan on NOX2 transcription following acute myocardial ischemia-reperfusion. Physiol Pharmacol. 2012 ; 16: 44-53
40. Nakatani T, Tsuboyama-Kasaoka N, Takahashi M, et al. Mechanism for peroxisome proliferator activated receptor-alpha activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes. J Biol Chem. 2002 ; 277: 9562-9569
41. Schupp M, Lee LD, Frost N, et al. Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites. Hypertension. 2006 ; 47: 586-589
42. Benson SC, Pershadsingh HA, Ho CI, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR-modulating activity. Hypertension. 2004 ; 43: 993-1002
43. Rossi GP. Losartan metabolite EXP3179: An AT1-receptor-independent treatment strategy for patients with the metabolic syndrome?. Hypertension. 2009 ; 54: 710-712